HOME >> BIOLOGY >> NEWS
NHLBI study finds improved heart failure survival

Survival after a heart failure diagnosis has greatly improved over the past 50 years, according to a study from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health. The study, which analyzed data from the NHLBI's landmark Framingham Heart Study (FHS), found that the risk of dying after being diagnosed with heart failure had dropped by about a third in men and women during that period.

The study, which appears in the October 31, 2002, issue of The New England Journal of Medicine, also found that new cases of heart failure had dropped by about a third for women during the same period. However, the number of new cases for men remained unchanged.

"These findings offer good news about a highly lethal disease," said NHLBI Director Dr. Claude Lenfant. "However, heart failure still affects far too many Americans and more than half of those who develop it die within 5 years of diagnosis.

"Prevention remains the best defense against heart failure. Americans can greatly reduce their chances of developing it by taking steps to prevent or control high blood pressure, heart disease, and other conditions that can lead to heart failure."

Heart failure occurs when the heart loses its ability to pump enough blood through the body. It often develops slowly, over many years. About 4.8 million Americans have heart failure, with about 550,000 new cases being diagnosed each year. Heart failure contributes to about 287,000 deaths a year.

In the new study, researchers, led by FHS Director Dr. Daniel Levy, analyzed data on 10,317 FHS participants drawn from the original enrollees and the offspring generation, including their spouses. The study had equal numbers of men and women.

The original participants, who began enrolling in FHS in 1948, were evaluated every 2 years; the offspring generation, which began enrolling in 1971, was evaluated in 1979 and every 4 years after that. The evalu
'"/>

Contact: NHLBI Communications Office
301-496-4236
NIH/National Heart, Lung, and Blood Institute
30-Oct-2002


Page: 1 2 3

Related biology news :

1. NHLBI awards $68 million to fund clinical centers in pediatric heart disease
2. NHLBI launches innovative proteomics centers
3. NHLBI study finds DASH diet and reduced sodium lowers blood pressure for all
4. NHLBI supported study finds inhaled steroids accelerate bone loss in women with asthma -- treatment still recommended for persistent asthma
5. NHLBI unveils new resources to help consumers control their blood pressure
6. NHLBI study shows reduced fat intake to lower cholesterol is safe and beneficial for children
7. Reducing sodium leads to substantial drop in blood pressure, finds NHLBI study
8. NHLBI launches genomic applications initiative -- $37 million awarded in initial effort
9. Two NHLBI studies confirm finding of gene in primary pulmonary hypertension
10. NHLBI study shows large blood pressure benefit from reduced dietary sodium
11. Student science contest participation influences study, career choices, alumni say

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/5/2020)... ... ... “Although we are disappointed to have to make this decision our primary ... We remain committed to creating a global platform to showcase the science, and ... of WMIS. , The abstract deadline for the virtual meeting is ...
(Date:6/2/2020)... ... June 02, 2020 , ... ... barcode and RFID labeling software developer and solutions provider, today reported that ... improved labeling accuracy and compliance by 100%, resulting in greater efficiency for ...
(Date:5/28/2020)... (PRWEB) , ... May 27, 2020 , ... CrucialTrak, a ... partner with New Jersey-based Critical Environments Group (CEG) to market and sell its complete ... of data center and IT environment infrastructure optimization solutions . , Brett ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... July 09, 2020 , ... ... (PTU) is commonly used to suppress pigment formation in zebrafish embryos, maintaining optical ... team led by Dr MA has been using the zebrafish model to investigate ...
(Date:7/7/2020)... ... 06, 2020 , ... R3 International is now offering stem cell therapy for ... cells. Depending on the patient's condition, treatment may be offered IV, intrathecal or with ... form of Alzheimers dementia, and the incidence continues to increase as individuals live longer. ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... growth of 40% in 2020, despite many obstacles created as a result of ... increase revenue for its partnered medical practices and medical manufacturers by expanding access ...
(Date:7/1/2020)... ... June 30, 2020 , ... ... launch of a new clinical diagnostics immuno-oncology service, TissueInsight . TissueInsight ... , “Flagship’s TissueInsight is a service that aids pathologists, oncologists, and immunologists ...
Breaking Biology Technology:
Cached News: